SGMT
Sagimet Biosciences Inc.
NASDAQ · Healthcare · Biotechnology · US
$8.86
+10.47%Margins
Gross margin
—
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
-18.4%
Return on equity
-17.9%
Return on assets
-20.4%
Return on invested capital
0.00x
Asset turnover
-$41.3M
Cash from operations
$3.39
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026